AstraZeneca has made a preliminary approach to rival drugmaker Gilead Sciences about a potential merger, as per sources in what would be the biggest healthcare deal on record. The UK-based firm informally contacted Gilead last month to gauge its interest in a possible tie-up, said sources, who added that AstraZeneca didn’t specify terms for any transaction.June 08, 2020 at 08:27AM
0 Comments